SEC 13F Intelligence

Highvista Strategies LLC / SLNOEUR

Highvista Strategies LLC’s Soleno Therapeutics Inc Position

Does Highvista Strategies LLC own Soleno Therapeutics Inc (SLNOEUR)? Yes — 165.2K shares worth $6M (+1.53% of its 13F portfolio) as of Q1 2026, up from 135.1K shares the prior filed quarter.

Position Value
$6M
Q1 2026
Shares
165.2K
% of Portfolio
+1.53%
Quarters Held
8
currently held

Position History SLNOEUR

Reported value by quarter
Q1 ’24: $446,318Q1 ’24Q3 ’24: $559,682Q3 ’24Q4 ’24: $644,763Q4 ’24Q1 ’25: $1MQ1 ’25Q2 ’25: $1MQ2 ’25Q3 ’25: $1MQ3 ’25Q4 ’25: $6MQ4 ’25Q1 ’26: $6MQ1 ’26filingsflow.com
QuarterSharesValue% of Portfolio
Q1 2026165.2K$6M+1.53%
Q4 2025135.1K$6M+1.61%
Q3 202518.7K$1M+0.31%
Q2 202512.9K$1M+0.40%
Q1 202514.3K$1M+0.39%
Q4 202414.3K$644,763+0.24%
Q3 202411.1K$559,682+0.19%
Q1 202410.4K$446,318+0.16%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Highvista Strategies LLC’s full portfolio or all institutional holders of SLNOEUR.